Rapid absorption and clinical effectiveness of intragastric mefloquine in the treatment of cerebral malaria in African children

J Antimicrob Chemother. 1999 Oct;44(4):573-6. doi: 10.1093/jac/44.4.573.

Abstract

To obviate the lack of injectable quinine in a hospital in rural Burundi, mefloquine, only available as an oral formulation, was administered (25 mg/kg bodyweight) as a single dose by nasogastric tube to four small children with cerebral malaria. All patients recovered uneventfully after a mean coma duration of 20.5 h. Mefloquine was rapidly absorbed and therapeutic serum concentrations were achieved within a few hours in all subjects, with parasite reduction ratios after 48 h within the expected range for drug-sensitive parasites. These findings suggest that intragastric mefloquine deserves consideration whenever parenteral drugs are not available for the treatment of cerebral malaria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorption
  • Antimalarials / therapeutic use*
  • Child, Preschool
  • Humans
  • Infant
  • Malaria, Cerebral / drug therapy*
  • Mefloquine / administration & dosage
  • Mefloquine / pharmacokinetics
  • Mefloquine / therapeutic use*

Substances

  • Antimalarials
  • Mefloquine